Patents
Patents for A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
04/2003
04/10/2003CA2461928A1 Solvent extraction process
04/09/2003EP1300084A2 Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves
04/09/2003EP1299119A2 Immunosuppressive compositions comprising an immunophilin-binding compound and a ginkgolide compound
04/09/2003EP1299112A2 Compositions for treating eye discomfort, containing herbals and/or nutritional supplements and/or minerals and/or vitamins
04/09/2003EP1299111A1 METHOD FOR PRODUCING NEMATOCIDAL COMPOSITION BY HEAT TREATING A pH-ADJUSTED FERMENTATION BROTH
04/09/2003EP1299081A1 Use of oligosaccharides to stimulate beta-endorphin production
04/09/2003EP1218021B1 Apple tree branch extracts for dermato-cosmetic use and method for preparing same
04/09/2003EP1150574A4 A natural tea for curing men's impotence and a method for manufacturing the same
04/09/2003EP1140885B1 Method for high yield extraction of paclitaxel from paclitaxel-containing material
04/09/2003EP1047496B1 The preparation of novel gels for the purification of non-polar extractives
04/09/2003EP0912191B1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine
04/09/2003EP0848612B1 Use of calendula glycosides for the treatment of psoriasis
04/09/2003EP0831726B1 Health food product
04/09/2003CN1409637A Skin-care agent, skin antiaging agent, whitening agent and external skin preparations
04/09/2003CN1409605A Method for increasing pet activity
04/09/2003CN1104905C Novel powder compositions
04/09/2003CN1104904C Natural tea for taking off the offect of drink and process for production thereof
04/09/2003CN1104897C Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor
04/09/2003CN1104855C Composition and its use as food supplement or for lowering lipids in serum
04/08/2003US6544566 For prophylaxis and minimizing development of atherosclerosis
04/08/2003US6544565 Administering to the host a pharmaceutically effective amount of 10(14)-Aromadendren-4-ol, 6, 10(14)- Guaiadien-4-ol, Valerenal, Valerenol, Valerenic acid, Acetoxyvalerenic acid, Hydroxyvalerenic acid or combinations thereof.
04/08/2003US6544564 Cytotoxic pharmaceutical composition
04/08/2003US6544563 Synergistic mixture of arginine and nitric oxide synthase
04/08/2003US6544557 Effervescent tablet compositions
04/08/2003US6544534 Conditioner that provides skin like an angel
04/08/2003US6544530 Stable oil-in-glycerin emulsion
04/08/2003US6544525 Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
04/08/2003US6544524 2-isopropyl-5-benzylidenedioxolan-4-one-2-carboxylic acid
04/08/2003US6544510 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
04/08/2003US6544509 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
04/08/2003US6544508 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799)
04/04/2003WO2002030436A1 Method for producing phyllanthus extracts
04/04/2003CA2424930A1 Method for producing phyllanthus extracts
04/03/2003WO2003027232A2 Method for producing biologically active products
04/03/2003WO2003026683A1 Health caring product for enhancing immunity and delaying aging
04/03/2003WO2003026620A1 Method for producing tablets from plant extracts
04/03/2003WO2003026594A2 Use of microcapsules containing ginger oil
04/03/2003WO2003026578A2 Pine cone extracts and uses thereof
04/03/2003WO2003026569A2 Composition and method for the treatment of hypercholesterolemia and hyperlipidemia in mammals
04/03/2003WO2003026565A2 Composition and treatment method for brain and spinal cord injuries
04/03/2003WO2003026561A2 Flavonoids for treatment of diabetes
04/03/2003WO2003026430A1 Treatment of allergic rhinitis
04/03/2003WO2003002133A3 Stabilisation of chlorophyll using medium chain triglyceride oils
04/03/2003WO2002030404A3 Combination therapy for premenstrual symptoms
04/03/2003WO2002007743A3 Piper methysticum plant extract
04/03/2003US20030065032 Topical applying of ointment
04/03/2003US20030064938 Cardiovascular disorders; menstraution disorders; anticancer agents
04/03/2003US20030064937 Synergistic mixture of procyanidin and citric acid
04/03/2003US20030064929 Modulating body/cranial hair growth
04/03/2003US20030064123 For increasing sexual responsiveness in a mammalian female
04/03/2003US20030064122 Pharmaceutical compound, and an amount of a capsaicin compound to deter intranasal, oral, and intravenous abuse while having little or no irritating effect when administered orally or transdermally as directed
04/03/2003US20030064121 For use as dietary supplement, in drugs, soy protein concentrate
04/03/2003US20030064120 Method for relaxing human beings using personal care compositions
04/03/2003US20030064119 Methods and compositions for applying essential oils and naturally occurring compounds to plants to activate endogenous plant pathogen defense pathways
04/03/2003US20030064118 Combination of Ginseng and Ginkgo to improve cognitive skills
04/03/2003US20030064117 For oral administration, injection and topical application
04/03/2003US20030064104 Shelf-stable, ready to use; to enhance delivery of active medicants/ingredients of pharmaceuticals, nutraceuticals, dietary supplements, therapeutics, diagnostics
04/03/2003US20030064099 Pharmaceutical formulation containing bittering agent
04/03/2003US20030064093 For therapeutic and cosmetic application
04/03/2003US20030064092 Pharmaceutical composition containing two active ingredients for smoking cessation
04/03/2003US20030064049 Topical anti-cancer compositions and methods of use thereof
04/03/2003US20030064048 Topically applying to skin formulation comprising one or more compounds derived from one or more of the botanical families leguminosae, solanaceae, gramineae and cucurbitaceae for effecting changes in mammalian hair appearance, hair growth
04/03/2003DE20213545U1 Jerusalem artichoke-celery schnapps, useful as e.g. a medicament, comprises spirit distilled from mixture of Jerusalem artichoke and celery with alcohol
04/03/2003CA2461563A1 Flavonoids for treatment of diabetes
04/02/2003EP1297837A1 Remedies for allergic diseases and process for producing the same
04/02/2003EP1297751A1 Composition to be administered orally
04/02/2003EP1296701A1 Use of grifola frondosa fungus extracts
04/02/2003EP1296700A1 Anti-carcinogenic activity of hydroxylated chalcone compounds extracted from licorice root
04/02/2003EP1296699A1 Therapeutic agents - iii
04/02/2003EP1296698A1 Therapeutic agents - ii
04/02/2003EP1296697A1 Therapeutic agents - i
04/02/2003EP1296696A1 Herbal composition for the treatment and curing of diseases
04/02/2003EP1296690A2 METHOD FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRUS /i INFECTIONS USING NUCLEOSIDE ANALOGUES
04/02/2003EP1263448A4 Maca and antler for augmenting testosterone levels
04/02/2003EP1153033B1 Method for purifying a red fruit extract containing anthocyanosides
04/02/2003EP0682877B1 Process for producing product from pulse and food containing product from pulse
04/02/2003CN1406625A Oral liquid
04/02/2003CN1406623A Levulose absorption retardant, compound, food and levulose absorption repressor
04/02/2003CN1406523A Oral liquid production
04/02/2003CN1406516A Healthy food
04/02/2003CN1104202C Aglucone isoflavone enriched vegetable protein extract and isolate and process for producing
04/02/2003CA2358158A1 Elastase inhibitors
04/01/2003US6541163 Process of powder for bath from natural plants
04/01/2003US6541049 Method for production of arachidonic acid
04/01/2003US6541046 Herbal composition and method for controlling body weight and composition
04/01/2003US6541045 Herbal composition and method for combating inflammation
04/01/2003US6541044 Kava-kava root composition and associated methods
04/01/2003US6541043 Method and synergistic composition for treating attention deficit/hyperactivity disorder
04/01/2003US6541042 Comprising 5-25% by weight terpinen-4-ol-containing essential oils and 0.01-10% by weight tannin-containing medicinal plants or extracts thereof, used for topical treatment of cutaneous and mucous membrane affections in veterinary sector
04/01/2003US6541041 Crude drug extracts, and methods for making and standardizing same
04/01/2003US6541026 Nutritional composition, methods of producing said composition and methods of using said composition
04/01/2003US6541006 Administration in a daily dose to a patient for reducing or controlling blood high density lipoproteins, a formulation containing between 50mg to 3.6 gm. red yeast rice, 5mg-600 mg coenzyme Q10 and between 5 IU to 800 IU mixed tocopherols
04/01/2003US6541005 Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
04/01/2003US6540998 Method for producing a nematocidal composition by heat treating a pH-adjusted fermentation broth
04/01/2003CA2317785C Liniment for topical application
04/01/2003CA2306578C Young leaves of a grass plant
04/01/2003CA2044676C Pharmaceutical composition for rectal administration of active principles exhibiting a prevalently topical medication action at the colon level
03/2003
03/27/2003WO2003025155A1 Fermentation product of cyptoporus volvatus and its preparation method and use
03/27/2003WO2003024487A1 Method of increasing the presence of glutathione in cells
03/27/2003WO2003024470A1 Standardized extracts of scutellaria lateriflora